Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
|Videos|December 5, 2017
What Input Is Key for Smart Infusion Pump Functionality?
In this clip, Baxter Pharmacy Consultant Jason Demuth discusses the importance of building a master library for smart pumps.
Advertisement
At the ASHP Midyear 2017 meeting, Baxter Pharmacy Consultant Jason Demuth discusses the importance of building a master library for smart pumps.
Advertisement
Related to this article
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
Phase 3 Krascendo 1 results suggest investigational divarasib could improve survival compared with currently approved KRAS G12C inhibitors in previously treated NSCLC.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
The once-nightly drop, previously approved to reverse pupil dilation, met its primary end point in 2 phase 3 trials, with conjunctival hyperemia most common.
Isatuximab on-body injector enables quick, hyaluronidase-free subcutaneous dosing, reducing reactions and easing multiple myeloma clinic workflows.
A summer PCAC vote pushes 6 peptide families toward the 503A bulks list—but the FDA's decision is still pending.
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
Advertisement
Advertisement
Trending on Pharmacy Times
1
Could Divarasib Challenge Existing KRAS G12C Inhibitors in Lung Cancer?
2
Fall 2026 Quiz: Test Your Pharmacy Knowledge!
3
Pharmacists Positioned as Key Educators as Monoclonal Antibodies Emerge as COVID-19 Immunization Option
4
Peptide Compounding Is Evolving: What Pharmacists Need to Know Now
5